Prosecution Insights
Last updated: October 02, 2026

Examiner: LEE, ANDREW ELDRIDGE

Tech Center 3600 • Art Units: 3626 3684

This examiner grants 17% of resolved cases

Analysis

Andrew Eldridge Lee is an examiner in Tech Center 3600 and Art Unit 3626. The profile shows 137 resolved cases with an allowance rate of 16.8 percent. This low rate indicates a challenging prosecution environment where the majority of cases do not result in an allowance. Practitioners should prepare for a rigorous examination process when assigned to this examiner.

The interview lift is 31.5 percent, which is a substantial increase. This figure suggests that interviews are a critical strategy for overcoming rejections. Applicants who engage in direct dialogue are significantly more likely to achieve an allowance than those who do not. The 31.5 percent lift is one of the most impactful metrics in this profile for guiding practitioner strategy in Art Unit 3626.

The median days to allowance is 1390. This long duration, combined with the 16.8 percent allowance rate, reflects a lengthy examination process. Practitioners should prioritize interviews to improve the probability of success and potentially shorten the 1390-day median timeline. The data from 137 cases provides a robust basis for these strategic considerations in Tech Center 3600.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

16.8%
Allow Rate
-35.2% vs TC avg
179
Total Applications
+31.5%
Interview Lift
1390
Avg Prosecution Days
Based on 137 resolved cases, 2023–2026

Rejection Statute Breakdown

36.5%
§101 Eligibility
10.7%
§102 Novelty
39.6%
§103 Obviousness
10.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18846553 DETERMINING A PATIENT’S RESPONSE TO A TREATMENT IN MULTIPLE MYELOMA Final Rejection Genentech, Inc.
19330070 SYSTEMS AND METHODS FOR ANALYSIS OF MULTI-RESOLUTION IMAGES Non-Final OA PAIGE.AI, Inc.
18619114 DATA PROCESSING SYSTEMS AND METHODS FOR IDENTIFYING NEW INDICATIONS FOR DRUGS Final Rejection Sanofi
18707100 DATA CAPTURE, PROCESSING, STORAGE AND RENDERING SYSTEM FOR BREATHING ASSISTANCE APPARATUS Non-Final OA Fisher & Paykel Healthcare Limited
18756923 Techniques for Dynamic Data Validation Final Rejection UNITEDHEALTH GROUP, INCORPORATED
18033136 TRANSMISSION OF ANALYSER SYSTEM DATA Non-Final OA RADIOMETER MEDICAL APS
17913786 ORCHESTRATION OF MEDICAL REPORT MODULES AND IMAGE ANALYSIS ALGORITHMS Final Rejection Smart Reporting GmbH
18655774 BEAT AND ECG DATA ANALYSIS PRIORITIZATION Final Rejection Boston Scientific Cardiac Diagnostics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month